Cleared Special

K112828 - REVIVE INTERMEDIATE CATHETER (REVIVE IC)

K112828 is the FDA 510(k) clearance for REVIVE INTERMEDIATE CATHETER (REVIVE IC) by Codman & Shurtleff, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 27-day FDA review.

K112828 · Codman & Shurtleff, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2011
Decision
27d
Days
Class 2
Risk

K112828 is an FDA 510(k) clearance for the REVIVE INTERMEDIATE CATHETER (REVIVE IC). Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Codman & Shurtleff, Inc. (Raynham, US). The FDA issued a Cleared decision on October 25, 2011 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Codman & Shurtleff, Inc. devices

Submission Details

510(k) Number K112828 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2011
Decision Date October 25, 2011
Days to Decision 27 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d faster than avg
Panel avg: 125d · This submission: 27d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 505
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K112828.
CLEARWAY RX NB CATHETER
K113112 · Atrium Medical Corp. · Nov 2011
RUBICON SUPPORT CATHETER
K112303 · Boston Scientific · Nov 2011
ATTAIN LDS 6216A LEFT HEART DELIVERY SYSTEM, ATTAIN ACCESS 6218A LEFT HEART DELIVERY SYSTEM, ATTAIN 6216A AND 6218A GUID
K112917 · Medtronic, Inc. · Oct 2011
SELECTRA ACCESSORY KIT
K111839 · Biotronik, Inc. · Sep 2011
SELECTRA SLITTER TOOL
K112482 · Biotronik, Inc. · Sep 2011
HEADWAY 27 MICROCATHETER
K110813 · MicroVention, Inc. · Aug 2011